Home › Inflammatory Bowel Disease › NCT00904878
A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women With Inflammatory Bowel Disease
Who can join
Ages 18 to 45 · Women
Full eligibility criteria
Inclusion Criteria: * Female patients with confirmed IBD diagnoses who are pregnant and taking immunosuppressants and/or biologic therapy Exclusion Criteria: * Pregnant female patients younger than 18 years of age * Confirmed multiple gestation
About the study
A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease study is being conducted at the University of California San Francisco and 30 other sites around the United States who are part of the CCFA Clinical Alliance. The aim of this study is to determine the effect of medication use and disease activity on the outcome of pregnancy among women with IBD up to 18 years from birth.
Sponsor: University of California, San Francisco · Participants: 1,500 · Started: 2007-08
Contact the study team
- Jessica Lim · Phone: 415-885-3734
- Nicole Arima · Phone: 415-514-8947
Official record on ClinicalTrials.gov — NCT00904878
Locations in the U.S.
| California | Please Contact Jessica Lim For Further Information Regarding Other Sites' Locations, San Francisco University of California San Francisco, San Francisco |
Conditions
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.